The detection value of tumor-related substances reached 240. What does this mean?

TSGF detection has broad spectrum, sensitivity, specificity and simplicity, and is an ideal tumor screening index. It can find a variety of early malignant tumors and can be used for early auxiliary diagnosis of cancer. In particular, the specificity of screening for healthy people is 99.35%. Tumor-related substances, also known as tumor markers, refer to substances that are characteristically present or abnormally produced in malignant tumor cells or substances produced by host cells (normal human cells) in response to tumors. Their expression in peripheral blood and other body fluids is closely related to the occurrence and development of malignant tumors, and most of them are glycoproteins, lipoproteins, enzymes, amino acids and other components. Clinical research shows that these substances exist not only in the body fluids of tumor patients, but also in the blood of normal people, but the content in the blood of tumor patients is significantly higher than that of normal people. When these substances increase significantly, it indirectly suggests the existence of tumors. It is necessary to go to the third-class first-class hospital for relevant examination, diagnosis and treatment in time.